Waters Corporation (NYSE:WAT) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts.

On March 18, 2026, Waters Corporation (NYSE:WAT) announced the pricing of a $3.5 billion senior notes offering through its subsidiary, Augusta SpinCo Corporation. The multi-tranche issuance features interest rates ranging from 4.321% to 5.245%.  Their maturities span from 2027 to 2036. The offering is expected to close around March 23, 2026. The company intends to utilize the proceeds from the offering to repay existing debts under a delayed draw term loan. Waters Corporation (NYSE:WAT) and some of its direct and indirect subsidiaries guarantee the Notes unconditionally, with Barclays serving as the global coordinator for the transaction.

In a separate event, Waters Corporation (NYSE:WAT) announced the launch of ARES-G3™ Rheometer on March 9, 2026. This next-generation instrument captures 25,000 data points per second (a tenfold increase) while reducing standard testing times by 80%, thereby setting a new industry benchmark for data quality at breakthrough speed. The ARES-G3 incorporates Fast Frequency Chirps, allowing scientists to monitor curing or degrading materials with a never-before-seen precision.

Founded in 1958, Waters Corporation (NYSE:WAT) is a global leader in life sciences and diagnostics, specializing in analytical technologies. Its headquarters is in Massachusetts.

While we acknowledge the potential of WAT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Stocks to Invest in During a Recession and 10 Best Space Exploration Stocks to Buy According to Analysts

Disclosure: None. Follow Insider Monkey on Google News.